Full‐length adiponectin protects hepatocytes from palmitate‐induced apoptosis via inhibition of c‐Jun NH2 terminal kinase
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Hepatic apoptosis is elevated in patients with non‐alcoholic steatohepatitis and is correlated with the severity of the disease. Long‐chain saturated fatty acids, such as palmitate, induce apoptosis in liver cells. The present study examined adiponectin‐mediated protection against saturated fatty acid‐induced apoptosis in the human hepatoma cell line, HepG2. Cells were cultured in a control media (i.e. without fatty acids) or the same media containing 250 μmol·L−1 of albumin‐bound oleate or palmitate for 24 h. The adiponectin concentrations used were: 0, 1, 10 or 100 μg·mL−1 (n = 4–6 per treatment). Palmitate and thapsigargin, but not oleate, activated caspase‐3 and decreased cell viability in the absence of adiponectin. Adiponectin reduced palmitate‐ and thapsigargin‐induced activation of caspase‐3 and cell death in a dose‐dependent manner. Phosphatidylinositol 3‐kinase and AMP‐activated protein kinase inhibitors abolished the effects of adiponectin. Adiponectin‐induced inhibition of palmitate‐ and thapsigargin‐induced apoptosis was not the result of an augmentation in the unfolded protein response or the increased expression of genes encoding the inhibitor of apoptosis proteins, inhibitor of apoptosis protein‐2 and X‐linked mammalian inhibitor of apoptosis protein. Palmitate and thapsigargin, but not oleate, increased c‐Jun NH 2 terminal kinase phosphorylation in the absence of adiponectin. Adiponectin blocked palmitate‐ and thapsigargin‐induced activation of c‐Jun NH 2 terminal kinase and reduced apoptosis. These data suggest that adiponectin is an important determinant of saturated fatty acid‐induced apoptosis in liver cells and may have implications for fatty acid‐mediated liver cell injury in adiponectin‐deficient individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759
de Vries, J. E., Vork, M. M., Roemen, T. H., de Jong, Y. F., Cleutjens, J. P., van der Vusse, G. J., & van Bilsen, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37421-6 · Cited by 324
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Cited by
Tanaka, S., Hikita, H., Tatsumi, T., Sakamori, R., Nozaki, Y., Sakane, S., Shiode, Y., Nakabori, T., Saito, Y., Hiramatsu, N., et al. (2016) · Hepatology · doi:10.1002/hep.28820 · Cited by 376
“1C), which is consistent with previous reports.((25,26)) The expression of light chain 3 (LC3)-II that is lipidation of LC3, an indicator of autophagosomes,((27)) increased in PA-supplemented cells, but not in OAsupplemented cells (Fig.”
ResultAdipokines in nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2015.11.006 · Cited by 348
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Polyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 311
Cytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282
“Notably, adiponectin protects hepatocytes from apoptosis, a hallmark of NAFLD, by inhibition of c-Jun NH2 terminal kinase (161).”
BackgroundThe role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Zavos, C., & Tsiaousi, E. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01176.x · Cited by 277
Metadata
- Authors
- Jung, T. W., Lee, Y. J., Lee, M. W., Kim, S. M., & Jung, T. W.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2009-03-23
- Volume
- 276
- Issue
- 8
- Pages
- 2278-2284
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1995878082
- Cited by
- 35
- References
- 6
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Full‐length adiponectin protects hepatocytes from palmitate‐induced apoptosis via inhibition of c‐Jun NH2 terminal kinase. https://app.cochat.ai/papers/10.1111/j.1742-4658.2009.06955.x
- The paper
- Jung, T. W., Lee, Y. J., Lee, M. W., Kim, S. M., & Jung, T. W. (2009). Full‐length adiponectin protects hepatocytes from palmitate‐induced apoptosis via inhibition of c‐Jun NH2 terminal kinase. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2009.06955.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.